Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Feb 16, 2015 - Advances and Progress in Drug Design

start date: Feb 16, 2015
Print

Event:

Advances and Progress in Drug Design


Starts:
Monday, February 16, 2015 at 10:00

Ends:
Tuesday, February 17, 2015 at 18:00

Location:
Marriott Hotel, Regents Park, London, United Kingdom

SMi are proud to present the 14th annual conference, Advances and Progress in Drug Design, taking place on 16th & 17th February 2015 in Central London.

Join us as we ask questions such as: What are the key challenges in biotherapeutics discovery? How have computational and predictive tools matured for the application of drug discovery? Are there novel ways to inhibit kinase targets? How can we successfully apply ligand-based and structure based computational approaches for the rational design of novel GPCR antagonists? What are the best approaches in building a robust technology pipeline for robust fragment based drug discovery?  

Hear case study driven presentations from an array of market leaders such as the University of Cambridge, Janssen, MedImmune, Sanofi and Novartis, discussing computational approaches, structure based drug design, pharmacokinetics, polypharmacology, drug metabolism and fragment based drug design, PLUS MUCH MORE!

KEY REASONS TO JOIN:

DISCUSS the application of computational based drug design with five presentations focusing on modelling and engineering 

JOIN the panel discussion on computational and predictive tools for the application of drug discovery 

ENHANCE your understanding of fragment-based drug design by listening to presentations led by UCB Pharmaceuticals, Astex Pharmaceuticals, ZoBio and the University of Birmingham 

LISTEN to talks on structure-based drug design from Lead Pharma, Sanofi, Novartis and Heptares Therapeutics

TOP SPEAKER LINE-UP INCLUDES:

Andreas Bender, Lecturer for Molecular, Informatics, University of Cambridge - CONFERENCE CHAIR

Dr Hugo Gutierrez de Teran, Senior Researcher, Division of Computational and Systems Biology, Uppsala University - CONFERENCE CHAIR

Gary Tresadern, Principal Scientist, Computational Chemistry, Lead Discovery, Janssen Research and Development

Henrik Moebitz, Investigator, Novartis

Sudharsan Sridharan, Scientist, MedImmune Ltd

Gianni Chessari, Director, Computational Chemistry, Astex Pharmaceuticals

Oliver Plettenburg, Head of Biosensors & Chemical Probes, Sanofi

Michael Overduin, Professor of Structural Biology, University of Birmingham

Dr Zara Sands, Principal Scientist, Medicinal Chemistry, UCB BioPharma

Richard Lewis, Executive Director, Computer-Aided Drug Design, Novartis

 

For further information click here

Media Partners

 

Exhibitions & Events